Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

PD-L1 immunohistochemistry correlates only moderately with patient survival and response to PD-(L)1 treatment. Heterogeneity of tumor PD-L1 expression might limit the predictive value of small biopsies. Here we show that tumor PD-L1 and PD-1 expression can be quantified non-invasively using PET-CT i...

Descripción completa

Detalles Bibliográficos
Autores principales: Niemeijer, A. N., Leung, D., Huisman, M. C., Bahce, I., Hoekstra, O. S., van Dongen, G. A. M. S., Boellaard, R., Du, S., Hayes, W., Smith, R., Windhorst, A. D., Hendrikse, N. H., Poot, A., Vugts, D. J., Thunnissen, E., Morin, P., Lipovsek, D., Donnelly, D. J., Bonacorsi, S. J., Velasquez, L. M., de Gruijl, T. D., Smit, E. F., de Langen, A. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220188/
https://www.ncbi.nlm.nih.gov/pubmed/30405135
http://dx.doi.org/10.1038/s41467-018-07131-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220188/
https://www.ncbi.nlm.nih.gov/pubmed/30405135
http://dx.doi.org/10.1038/s41467-018-07131-y

Ejemplares similares